MV-Age
2 papers2 findings
- Humans1
- In silico1
Upstream
1Depressive disorder
downin silico1OR 0.924
1 study
Depressive disorder
downin silico1OR 0.924
Depressive disorder decreases MV-Age in silico (OR 0.924, 95% CI 0.913–0.935, P = 1.53 × 10−39).
“depressive disorders were associated with accelerated biological aging, as reflected by lower MV-Age (OR = 0.924, 95 %CI: 0.913-0.935, P = 1.53 × 10−39)”
In silico
Journal of affective disorders6 Dec 2025
Associations
1Depressive disorder
downin silico1OR 0.654
1 study
Depressive disorder
downin silico1OR 0.654
MV-Age lowers the risk of depressive disorder in silico (OR 0.654, 95% CI 0.535–0.799, P = 3.34 × 10−5).
“Conversely, higher MV-Age was associated with a reduced risk of depressive disorders (OR = 0.654, 95 %CI: 0.535-0.799, P = 3.34 × 10−5).”
In silico
Journal of affective disorders6 Dec 2025
Latest
2 in 12 monthsVirus Research
Biological Aging, Immune Phenotypes, and Susceptibility to COVID-19 and Sepsis: A Mendelian Randomization Study
Computational studyImmune response
Journal of Affective Disorders
Depressive disorder in middle-aged and elderly adults: Evidence from global burden of disease and genetic analysis
Mendelian randomisation in peopleDepressive disorder